A crisis can break in an instant. Are you prepared? Use our eBook to develop a plan. Download Now

Westicke Partners

Close

Westwicke Blog

The Westwicke Blog is designed to deliver information and insights into the ever-changing world of healthcare communications.

10 Disclosure Guidelines for Clinical Trial Data and Milestones

Posted on October 21st, 2020. Posted by

As life science and medical device companies seek regulatory approval for their products, they will likely encounter difficult disclosure decisions around clinical and regulatory events. Clinical trial data and milestones can present great opportunities as well as significant challenges.

If done right, these milestones are a great way to raise visibility within the investment, clinical, and scientific communities. If done wrong, the consequences may be severe.

The checklist below outlines 10 disclosure guidelines that will allow you to control the message within the investment and medical communities, maximize shareholder value, and attract new investors and strategic partners.

 

Clinical Trials Disclosure

 

Tom McDonald

Tom McDonald is a Partner/Managing Director and Head of Business Development. He is responsible for marketing the firm’s capabilities to potential new clients as well as the institutional investment community.

View full bio   |   Other posts by Tom McDonald

Ensure the success of your next M&A transaction.

Learn how to design and execute an M&A communications program that inspires confidence, reduces uncertainty, and generates stakeholder buy-in and support in our eBook, M&A Communications: 5 Keys to Success. Download Now.

Our Locations